Combination of Mycophenolate Mofetil and Tacrolimus for Refractory Lupus Nephritis: A 12-Month Open-Labeled Trial.

被引：0

作者：

Mok, Chi Chiu ^{[1
]}

Chan, Pak To ^{[1
]}

Ho, Ling Yin ^{[1
]}

Yu, Ka Lung ^{[1
]}

机构：

[1] Tuen Mun Hosp, Hong Kong, Hong Kong, Peoples R China

来源：

ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1414

引用

页码：S608 / S609

页数：2

共 48 条

[21] LONG-TERM OUTCOME OF A RANDOMIZED CONTROLLED TRIAL COMPARING TACROLIMUS WITH MYCOPHENOLATE MOFETIL AS INDUCTION THERAPY OF SEVERE LUPUS NEPHRITIS [J].

Mok, C. C. ;

Ho, L. Y. ;

To, C. H. ;

Ying, K. Y. S. .

ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 :104-104

[22] COMPARATIVE EFFICACY OF INTRAVENOUS CYCLOPHOSPHAMIDE, MYCOPHENOLATE MOFETIL, AND TACROLIMUS AS INDUCTION THERAPY FOR LUPUS NEPHRITIS: A RANDOMIZED CONTROLLED OPEN-LABEL NON-INFERIORITY TRIAL [J].

Amudalapalli, A. ;

Sahoo, R. R. ;

Shukla, A. ;

Maddineni, A. ;

Nagar, S. ;

Sridhar, R. ;

Gowda, S. G. H. ;

Madan, S. ;

Sasmal, G. ;

Patro, P. S. .

ANNALS OF THE RHEUMATIC DISEASES, 2025, 84

[23] Long-term Outcome of a Randomized Controlled Trial Comparing Tacrolimus with Mycophenolate Mofetil as Induction Therapy of Severe Lupus Nephritis [J].

Mok, Chi Chiu ;

Ho, Ling Yin ;

Ying, Shirley ;

Ng, Woon Leung ;

Leung, Man Chi .

ARTHRITIS & RHEUMATOLOGY, 2019, 71

[24] Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis [J].

Mok, Chi Chiu ;

Ho, Ling Yin ;

Ying, Shirley King Yee ;

Leung, Man Chi ;

To, Chi Hung ;

Ng, Woon Leung .

ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (08) :1070-1076

[25] MULTI-TARGET THERAPY USING A COMBINATION OF TACROLIMUS AND MYCOPHENOLATE MOFETIL IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A FOLLOW-UP REPORT [J].

Hidekazu, Ikeuchi ;

Keiju, Hiromura ;

Kadiombo, Tshilela A. ;

Ken, Kayakabe ;

Noriyuki, Sakurai ;

Toru, Sakairi ;

Yoriaki, Kaneko ;

Akito, Maeshima ;

Yoshihisa, Nojima .

NEPHROLOGY, 2014, 19 :150-150

[26] Correspondence on 'Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis' [J].

Xu, Chuanhui .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12)

[27] Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up [J].

Mok, Chi Chiu ;

Ying, King Yee ;

Yim, Cheuk Wan ;

Siu, Yui Pong ;

Tong, Ka Hang ;

To, Chi Hung ;

Ng, Woon Leung .

ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (01) :30-36

[28] Safety and efficacy of leflunomide in the treatment of lupus nephritis refractory to traditional immunosuppressive therapy: An open-label trial. [J].

Tam, LS ;

Li, EK ;

Wong, CK ;

Lam, CW ;

Szeto, CC .

ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :S195-S196

[29] Response to: 'Correspondence on 'Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis'' by Xu [J].

Mok, Chi Chiu .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12)

[30] Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data [J].

Qazi, Y. ;

Shaffer, D. ;

Kaplan, B. ;

Kim, D. Y. ;

Luan, F. L. ;

Peddi, V. R. ;

Shihab, F. ;

Tomlanovich, S. ;

Yilmaz, S. ;

McCague, K. ;

Patel, D. ;

Mulgaonkar, S. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (05) :1358-1369

← 1 2 3 4 5 →